Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
Sam Schulman(Hamilton General Hospital), Mats O. Beckman(Karolinska University Hospital), Stanka Viering, Margareta Holmström(Integrated Cardio Metabolic Centre), Barbro Leijd(Saint Göran Hospital), Bengt Ljungberg, Khatoon Jahed(Linköping University Hospital), Gerd Lärfars, Ollie Linder(Örebro University Hospital), Else Svensson, Peter Nicol, Per Lindmarker, Martin Hjorth(Integrated Cardio Metabolic Centre), Anders Carlsson, Sune Nordlander(Västerås Municipality)
Cited by 507
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k